Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-21-000024

Options or other derivatives

  • Director acquired 1,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baxter Nicholas W · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-01 Grant or award : show line 1 in the form Stock Options +1,900 8,400 D
Loading xslF345X03/primary_doc.xml…